Assignee
TASLY BIOPHARMACEUTICALS CO LTD
CN·2 granted patents·2 pending applications·0 citations·filing 2018–2024
Top patents by PatentIndex Score
4 records- 0165US2025042964A1Method of treating nash using a long-acting mutant human fibroblast growth factorTASLY BIOPHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 0259US12152059B2Method of treating nash using a long-acting mutant human fibroblast growth factorTASLY BIOPHARMACEUTICALS CO LTD·Filed 2019·Granted Nov 26, 2024·0 cites·8 claims
- 0351US2025075172A1Production method for bispecific antibodyTASLY BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0432US11655308B2HM-3 fusion protein and application thereofTASLY BIOPHARMACEUTICALS CO LTD·Filed 2018·Granted May 23, 2023·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when TASLY BIOPHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →